CYP 9.30% 23.5¢ cynata therapeutics limited

KILIAN KELLY INTERVIEW, page-9

  1. 1,070 Posts.
    lightbulb Created with Sketch. 546
    When we have MSB setting the example for stem cell companies on the ASX (over the last decade), I don't blame the big money for not coming in yet. Their all afraid of a re-trace of MSB's share-price.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.